(rituximab, ocrelizumab, obinutuzumab), BLyS/BAFF inhibitors (belimumab, tabalumab), Interferon-Î± receptor inhibitor (anifrolumab) | <strong>Colchicine</strong>                                                                                                       | <strong>Seasonal influenza</strong><br><strong>PPSV23, PCV13</strong><br><strong>Hemophilus influenza b</strong><br><strong>Hepatitis A</strong><br><strong>Hepatitis B</strong><br><strong>Human